Bharat Biotech has been granted permission by India's drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19.

Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands..

It doesn't come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time, just hoping for an access to success over the other, be it new launches or even drug trials, which have been happening round the clock...